ADMA Biologics Inc vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? ADMA Biologics Inc trades at $9.84 (market cap $2.22B), while Direxion Daily FTSE China Bull 3x Shares trades at $29.2. Which is the better fit depends on your goals.
| ADMA | YINN | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $20.38 | $56.62 |
52-Week Low | $7.60 | $21.45 |
Enterprise Value | $2.29B | — |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →